Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Schittenhelm

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Medical Oncology (Northwood, London, England)|December 1, 2014
CNS metastases in breast cancer patients: prognostic implications of tumor subtypeC Bachmann, S Schmidt, A Staebler, et al.
Neuropathology and Applied Neurobiology|October 21, 2017
Low FoxG1 and high Olig-2 labelling indices define a prognostically favourable subset in isocitrate dehydrogenase (IDH)-mutant gliomasS Schäfer, F Behling, M Skardelly, et al.
Clinical Neuropathology|February 9, 2008
The clinico-surgico-pathological spectrum of myxopapillary ependymomas--report of four unusal cases and review of the literatureJ Schittenhelm, R Becker, D Capper, et al.
Zeitschrift Fur Geburtshilfe Und Neonatologie|October 27, 2011
[Neonatal intracerebral bleeding as initial symptom of gliomatosis cerebri WHO III--neurological outcome after partial hemispherectomy]A Wacker-Gussmann, F Neunhoeffer, M Alber, et al.
Journal of Neurology|November 28, 2009
Intracranial hemangiomas in a patient with POEMS syndromeG D Maurer, J Schittenhelm, U Ernemann, et al.
Neuropathology and Applied Neurobiology|March 16, 2007
The astrocytic response towards invasive meningiomasL Zeltner, J Schittenhelm, M Mittelbronn, et al.
Oncogene|May 26, 2009
Aryl hydrocarbon receptor inhibition downregulates the TGF-beta/Smad pathway in human glioblastoma cellsD Gramatzki, G Pantazis, J Schittenhelm, et al.
Clinical Neuropathology|August 1, 2009
Concepts and developments in peripheral nerve surgeryN Sinis, A Kraus, N Papagiannoulis, et al.
Neuropathology and Applied Neurobiology|March 21, 2009
Erythropoietin receptor is expressed in meningiomas and lower levels are associated with tumour recurrenceO Küster, P Simon, M Mittelbronn, et al.
Neuropathology and Applied Neurobiology|May 10, 2008
Diagnostic value of WT1 in neuroepithelial tumoursJ Schittenhelm, R Beschorner, P Simon, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Medical Oncology (Northwood, London, England)|December 1, 2014
CNS metastases in breast cancer patients: prognostic implications of tumor subtypeC Bachmann, S Schmidt, A Staebler, et al.
Neuropathology and Applied Neurobiology|October 21, 2017
Low FoxG1 and high Olig-2 labelling indices define a prognostically favourable subset in isocitrate dehydrogenase (IDH)-mutant gliomasS Schäfer, F Behling, M Skardelly, et al.
Clinical Neuropathology|February 9, 2008
The clinico-surgico-pathological spectrum of myxopapillary ependymomas--report of four unusal cases and review of the literatureJ Schittenhelm, R Becker, D Capper, et al.
Zeitschrift Fur Geburtshilfe Und Neonatologie|October 27, 2011
[Neonatal intracerebral bleeding as initial symptom of gliomatosis cerebri WHO III--neurological outcome after partial hemispherectomy]A Wacker-Gussmann, F Neunhoeffer, M Alber, et al.
Journal of Neurology|November 28, 2009
Intracranial hemangiomas in a patient with POEMS syndromeG D Maurer, J Schittenhelm, U Ernemann, et al.
Neuropathology and Applied Neurobiology|March 16, 2007
The astrocytic response towards invasive meningiomasL Zeltner, J Schittenhelm, M Mittelbronn, et al.
Oncogene|May 26, 2009
Aryl hydrocarbon receptor inhibition downregulates the TGF-beta/Smad pathway in human glioblastoma cellsD Gramatzki, G Pantazis, J Schittenhelm, et al.
Clinical Neuropathology|August 1, 2009
Concepts and developments in peripheral nerve surgeryN Sinis, A Kraus, N Papagiannoulis, et al.
Neuropathology and Applied Neurobiology|March 21, 2009
Erythropoietin receptor is expressed in meningiomas and lower levels are associated with tumour recurrenceO Küster, P Simon, M Mittelbronn, et al.
Neuropathology and Applied Neurobiology|May 10, 2008
Diagnostic value of WT1 in neuroepithelial tumoursJ Schittenhelm, R Beschorner, P Simon, et al.
Pageof 4